🐂 Not all bull runs are created equal. November’s AI picks include 5 stocks up +20% eachUnlock Stocks

GLOBAL MARKETS-Stocks gain, bonds fall as vaccine-fuelled rotation ploughs on

Published 11/11/2020, 11:14 pm
Updated 11/11/2020, 11:18 pm
© Reuters.
EUR/USD
-
USD/JPY
-
USD/TRY
-
US500
-
GS
-
AV
-
PFE
-
DX
-
LCO
-
ESZ24
-
CL
-
DE10YT=RR
-
US10YT=X
-
STOXX
-
MIAPJ0000PUS
-
MIWD00000PUS
-
SX8P
-
SXTP
-
BNTX
-

* Euro STOXX 600 up 0.9%

* Wall Street futures up 0.7%

* Investors rotate to beaten-down sectors

* German Bund yields hit 2-month high

* Brent crude breaks $45 for first time since Sept

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

By Tom Wilson

LONDON, Nov 11 (Reuters) - Stocks gained and bonds dropped on Wednesday as prospects of an effective COVID-19 vaccine outweighed nagging worries over surging infections, fuelling a rotation towards cut-price losers from the coronavirus pandemic such as travel stocks.

The broad Euro STOXX 600 .STOXX climbed 0.9%, gaining steam through the morning and building on a 5% rally this week to hit its highest since early March.

Beaten-down equities were in demand, with travel-related stocks .SXTP gaining 1.2%. Tech companies .SX8P , which like their U.S. counterparts have surged since March's coronavirus crash as lockdowns have pushed people to work and shop online, turned positive after opening in the red.

Wall Street futures gauges also climbed, with S&P 500 futures ESc1 up 0.8%.

Bonds also adjusted to the prospect of a post-pandemic world, with the yield on German Bunds DE10YT=RR , a benchmark for euro zone sovereign debt, rising to their highest for two months at -0.456%. yield on benchmark 10-year U.S. Treasuries US10YT=RR posted on Tuesday its highest close since March, though U.S. bond markets are shut on Wednesday. Bond yields rise when prices fall.

"The market is not wrong -- we know who benefited during COVID, and it was almost inevitable that if COVID comes to an end, you would have a reversal on that," said Luca Paolini, chief strategist at Pictet Asset Management.

The MSCI world equity index .MIWD00000PUS , which tracks shares in almost 50 countries, gained 0.2% to move close to its record high touched on Monday.

Earlier, Asia-Pacific shares outside Japan .MIAPJ0000PUS nudged up 0.2%, even as Chinese tech stocks .CSIINT fell sharply over concerns about tighter regulation. ROTATE

Investors have pivoted to riskier plays in equities, foreign exchange and bonds after Pfizer Inc (NYSE:PFE) PFE.N said on Monday its COVID-19 vaccine candidate, developed with BioNTech BNTX.O , showed a 90% success rate in preventing infection during trials. $2 trillion changed hands on Monday alone, one of the heaviest trading days since the height of the pandemic crisis. Tech stocks, among the major winners in the pandemic, have lost out, as have safe-haven currencies like the Japanese yen JPY= . have seen a big rotation which highlighted how skewed positioning was, as people sheltered in the work-from-home plays," said Richard Saldanha, a portfolio manager at Aviva (LON:AV) Investors.

"For names geared towards so-called normalisation of activity, (the rally) could continue to play out in coming days."

Goldman Sachs (NYSE:GS) lifted its 2020 S&P 500 .SPX target to 3,700 points as the vaccine news added momentum to a stock market rally sparked by Joe Biden's U.S. election win. It sees the S&P 500 hitting 4,300 at year-end 2021, a fifth higher than Tuesday's closing levels. Brent oil rose to a more than two-month high above $45 a barrel, fuelled by vaccine prospects and an industry report showing U.S. crude inventories fell more than expected. O/R

Brent futures LCOc1 were up $1.41, or 3.2%, at $45.02 -- the first time they have cleared the $45 threshold since early September.

A rotation of sorts is also underway in fixed income markets, as bonds in Japan, South Korea, Singapore and Thailand fell while higher-yielding, riskier debt of countries like Indonesia held gains.

In currency markets, Turkey's lira TRYTOM=D3 gained 3% to pass 7.9 to the dollar as President Tayyip Erdogan said his government was forming a new growth strategy, financed in part by international investment. hit its highest level in more than two months versus the euro GBP=D3 as traders bet a vaccine would boost the UK economy. It was last flat at $1.3265.

The euro EUR= fell 0.3% to $1.1786 ahead of a speech from European Central Bank President Christine Lagarde at 1300 GMT.

The dollar steadied against a basket of six major currencies =USD and by late morning was up 0.2% at 92.927.

<^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ Global assets

http://tmsnrt.rs/2jvdmXl Global currencies vs. dollar

http://tmsnrt.rs/2egbfVh Emerging markets

http://tmsnrt.rs/2ihRugV MSCI All Country Wolrd Index Market Cap

http://tmsnrt.rs/2EmTD6j

^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^>

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.